
Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine ...
See Prescribing Information, including Boxed Warning. Find information for healthcare professionals about once-daily AUSTEDO XR.
AUSTEDO® XR: Tardive Dyskinesia and Huntington's Chorea …
AUSTEDO® XR (deutetrabenazine) extended-release tablets is the first medication approved to treat both tardive dyskinesia and Huntington's disease chorea. See safety info including Boxed …
Austedo (deutetrabenazine): Uses, Side Effects, Dosage Guide
Aug 20, 2025 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more
AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR ...
Nov 7, 2025 · AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting …
Austedo: Regaining Control Over Uncontrolled Movements in ...
Jul 16, 2024 · Tardive dyskinesia (TD) is a disorder that can cause repetitive movements such as twitching, shaking, or jerking in the arms, legs, face (including eyes and mouth), and torso. …
Pharmacology Vesicular monoamine transporter 2 (VMAT2) is a protein that regulates the packaging and release of monoamines (dopamine, serotonin, norepinephrine, and histamine). …
Austedo Phase 4 Data Shows Reduction in Tardive Dyskinesia ...
Nov 12, 2025 · New phase 4 data reveals Austedo significantly reduces involuntary movements and enhances quality of life for adults with tardive dyskinesia.
Are Your Movement Symptoms Akathisia or Tardive Dyskinesia?
2 days ago · Akathisia and tardive dyskinesia are medication-related movement disorders with distinct causes and treatments. Learn the signs and risks.
Austedo (Deutetrabenazine): Uses & Side Effects
Austedo is a brand of deutetrabenazine. This medication treats involuntary movements caused by tardive dyskinesia or Huntington's disease.
The Sun: Local News, Sports and Things to Do - AUSTEDO ...
Nov 7, 2025 · AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting …